FCH
AGN

Freestone Capital Holdings’s Allergan Inc AGN Stock Holding History

Freestone Capital Holdings’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-9,667
Closed -$2.06M – 212
2014
Q4 		$2.06M Buy
9,667
+29
+0.3% +$5.77K 0.34% 41
2014
Q3 		$1.72M Sell
9,638
-12,098
-56% -$2.01M 0.3% 52
2014
Q2 		$3.68M Buy
21,736
+11,515
+113% +$1.79M 0.57% 33
2014
Q1 		$1.27M Sell
10,221
-3,317
-25% -$404K 0.22% 77
2013
Q4 		$1.5M Sell
13,538
-1,123
-8% -$107K 0.27% 55
2013
Q3 		$1.33M Buy
14,661
+2,422
+20% +$217K 0.24% 79
2013
Q2 		$1.03M Buy
+12,239
New +$1.27M 0.21% 74

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Freestone Capital Holdings's AGN Position: Q1 2015 in Review

Freestone Capital Holdings sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 9,667 shares — an estimated $2.06M sold.

Freestone Capital Holdings first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $3.68M in Q2 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Freestone Capital Holdings reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Freestone Capital Holdings sold 9,667 Allergan Inc shares in Q1 2015, an estimated $2.06M.
  • Freestone Capital Holdings first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Freestone Capital Holdings's Allergan Inc position peaked at $3.68M in Q2 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Freestone Capital Holdings's 13F filing for Q1 2015, filed 11 May 2015.